Onkologie 1991;14:[removed]Treatment of Advanced Malignant Melanoma by a Pyrogenic Bacterial Lysate. A Pilot Study K. F. Kölme[a, K. Vehmeyerb, E. Göhringc, B. Kuhna, J. V. Wiedingb a Hautklinik und

First Page		Document Content
Date: 2013-03-04 14:01:05 Anatomy Cytokines Antithrombin Disseminated intravascular coagulation Melanoma Endotoxin Tumor necrosis factor-alpha Coagulation Serratia Medicine Coagulation system Biology		Onkologie 1991;14:[removed]Treatment of Advanced Malignant Melanoma by a Pyrogenic Bacterial Lysate. A Pilot Study K. F. Kölme[a, K. Vehmeyerb, E. Göhringc, B. Kuhna, J. V. Wiedingb a Hautklinik und Add to Reading List Source URL: www.archemed.de Download Document from Source Website File Size: 1.021,26 KB Share Document on Facebook

	Biomolecular Interaction and The Interactome.doc DocID: 1pQMx - View Document
	Domestic Sales Outsourcing Agreement for Recombinant Human Antithrombin Preparation Signed Tokyo, Japan, July 30, The Japan Blood Products Organization (head office: Tokyo, Japan, President and representative di DocID: 1lLMs - View Document
	Paris, 19 MayPress releaseGTC BIOTHERAPEUTICS Inc., a LFB group company, granted protection until 2027 on broad transgenic protein production patent, and is also granted new patent on recombinant antithrombin pro DocID: 1aPBm - View Document
	Routine Coagulation Reagents Activated Partial Thromboplastin Time (aPTT) Antithrombin III (ATIII) Prothrombin Time (PT) Thrombin Time (TT) Fibrinogen DocID: 1aOgJ - View Document
	HAEMATOLOGIC TECHNOLOGIES INCResearch Reagents Catalog DocID: 1apfC - View Document